Thursday, April 19
11:30 am - 12:15 pm

Lunch Reception

12:15 pm - 4:45 pm


12:15 pm - 12:30 pm

Welcome and Introductions

Policy Forum Moderator: Ian Spatz, Senior Advisor, Manatt Health

12:30 pm - 1:00 pm

Perspectives on Prescription Drug Issues from Capitol Hill

Alyssa Palisi, Professional Staff Member, House Committee on Ways and Means

Rachel Pryor, Senior Health Policy Advisor, House Committee on Energy and Commerce

Brett Baker, Senior Health Policy Advisor, Senate Committee on Finance (invited)

1:00 pm - 1:30 pm

Point of Sale Rebates: Opportunities in Commercial Benefits

Lida Etemad, Vice President, Pharmacy Management Strategies, Employer & Individual and Community & State, UnitedHealthcare

1:30 pm - 2:00 pm

Perspectives from HHS

John O’Brien, Advisor to the Secretary & Deputy Assistant Secretary for Health Policy, U.S. Department of Health and Human Services

2:00 pm - 2:30 pm

Outside the Beltway: State Perspectives on Prescription Drug Benefits

Representative MaryLynn Magar, Florida House – District 82 (R)

Representative Kevin Roberts, Texas House – District 126 (R)

J.P. Wieske, Deputy Commissioner of Insurance, State of Wisconsin

2:30 pm - 3:00 pm

The Value of Specialty Pharmacy: Patient Engagement, REMS and Biosimilars

Brian Seiz, Senior Vice President, Specialty, Express Scripts & President, Accredo Specialty Pharmacy

3:00 pm - 3:30 pm

How PBMs are Driving Value Based Contracting

Kim Gwiazdzinski, Senior Director, Trade Relations, Value and Outcomes Contracting, Prime Therapeutics

3:30 pm - 4:00 pm

Perspectives from FDA

Scott Gottlieb, Commissioner of Food and Drugs, U.S. Food & Drug Administration

4:00 pm - 4:30 pm

Employers’ Perspectives on Drug Benefit Management

Kevin Host, President & Chief Operating Officer, PSG Consulting

4:30 pm - 4:45 pm

PCMA Perspectives and Wrap Up